he evolution of laser vision correction technology has made the treatment of myopia, hyperopia, and astigmatism more accurate. Numerous studies of hyperopic LASIK have been reported, [1] [2] [3] [4] [5] [6] [7] and as the WaveLight Allegretto Wave laser (Alcon Laboratories Inc, Ft Worth, Texas) was introduced, reports of wavefront-optimized hyperopic LASIK have also been published. 8, 9 We previously reported the use of topography-guided excimer laser ablations for hyperopia and their advantage in correcting angle kappa.
METHODS:
Thirty-four consecutive patients with hyperopia and hyperopic astigmatism elected to have bilateral topography-guided LASIK and were randomized to receive a single drop of 0.1% sodium phosphate ribofl avin solution under the fl ap followed by 3-minute exposure of 10 mW/cm 2 ultraviolet A (UVA) light with the fl ap realigned in one eye (CXL group) and no intrastromal CXL in the contralateral eye (no CXL group). All eyes were treated with the WaveLight FS200 femtosecond laser and WaveLight EX500 excimer laser (Alcon Laboratories Inc). Refractive error and keratometric, topographic, and tomographic measurements were evaluated over mean follow-up of 23 months. CONCLUSIONS: Topography-guided hyperopic LASIK with or without intrastromal CXL is safe and effective, with greater long-term effi cacy (less regression) in eyes with CXL. Our data suggest that the regression seen with hyperopic LASIK may be related to biomechanical changes in corneal shape over time. Thirty-four patients (68 eyes) underwent bilateral topographic-guided hyperopic LASIK in our facility from March 2010 to October 2010, with one eye randomized (by coin toss) to receive prophylactic instrastromal CXL. Inclusion criteria were hyperopia of ϩ0.25 to ϩ8.00 diopters (D) and astigmatism up to Ϫ6.00 D with a spherical equivalent cycloplegic refraction р6.00 D. Exclusion criteria were previous corneal surgery, history of herpetic eye disease, corneal dystrophy, corneal scarring, keratoconus, severe dry eye, or collagen vascular diseases.
RESULTS:
Preoperative evaluation included uncorrected distance visual acuity (UDVA), refraction (cycloplegic), corrected distance visual acuity (CDVA), slit-lamp examination including fundus evaluation, corneal imaging with Scheimfl ug corneal tomography (Oculyzer II, Alcon Laboratories Inc) and Placido disc-based topography (Vario, Alcon Laboratories Inc), ultrasound central corneal pachymetry with the NIDEK US-1800 (Echoscan, Achi, Japan), and wavefront analysis with the Allegretto-Wave Tscherning wavefront analyzer (WaveLight Technologie AG, Erlangen, Germany) measured at 6.5-mm pupil size. Contrast sensitivities were also measured using CSV-1000 (VectorVision, Arcanum, Ohio).
A custom nomogram-adjustment algorithm for determining the ablation treatment plan was used per our previous experience. As an important differentiator, this algorithm was used to compensate for the regression encountered in earlier cases; however, this nomogram-adjusted algorithm was not used in eyes randomized to receive intrastromal CXL.
SURGICAL TECHNIQUE
A disposable patient interface was used for fl ap creation in each eye treated with the FS200 femtosecond laser (Alcon Laboratories Inc). One drop of proparacaine 1% (Alcaine, Alcon Laboratories Inc) was instilled in the patient's eye just before the procedure. Eyelids were painted with povidone iodine antiseptic 10% (Betadine; Purdue Pharma L.P., Stamford, Connecticut), and the eye lashes were isolated with sterile plastic drapes (Tegaderm; 3M Health Care, St Paul, Minnesota). The femtosecond laser was used to cut the corneal fl aps in all cases. The fl aps were cut to expose a stromal bed at a diameter of at least 9.0 mm and depth of 135 μm, which was suffi ciently large for the hyperopic (large diameter) ablation and its accompanying blend zone. The intraoperative fl ap diameter was measured with a surgical caliper, and pachymetry measurement of the residual stromal bed was done with the built-in optical pachymeter of the EX500. The 500-Hz EX excimer laser was used to perform the ablations in all cases using the topography-guided platform. Images were taken from the Oculyzer II as described previously. 12 At the completion of the excimer ablation, eyes that were randomized to receive CXL were given one drop of our custom 0.1% ribofl avin sodium phosphate solution (Leiter's Pharmacy, San Francisco, California), on the bare stromal bed, which was left to soak for 60 seconds. Special care was taken not to allow the ribofl avin solution to come in contact with the already folded LASIK fl ap (Fig 1) . After 60 seconds of soaking, the LASIK fl ap was refl ected into place and copiously irrigated and "ironed" in place with a Johnston applanator (Rhein Medical, Tampa, Florida) (Fig 2) .
Immediately afterwards, one drop of Vigamox solution (Alcon Laboratories) was applied to the cornea and it was illuminated with 10 mW/cm 2 of 370-nm UV light with the KXL device (Avedro, Waltham, Massachusetts) for a total of 3 minutes. No additional drops Topography-guided Hyperopic LASIK and CXL/Kanellopoulos & Kahn of ribofl avin were administered. The surface was kept moist with two to three drops of Vigamox during the 3-minute interval. A bandage contact lens was placed on the ocular surface, and the patient was prescribed Vigamox and 1% prednisolone acetate (PredForte; Allergan, Irvine, California) four times a day for 1 week. Patients were examined 30 minutes postoperatively to check for any fl ap irregularities or complications.
Postoperatively, UDVA, CDVA, corneal tomography and topography, and manifest and cycloplegic refraction were evaluated. These examinations were repeated during follow-up at 1 day, 1 week, and 1, 3, and 6 months, and every 6 months thereafter. All surgeries were performed by a single surgeon (A.J.K.) in an outpatient refractive surgery center in Athens, Greece. Measurements and data were obtained by the surgeon and his associate staff. Figure 3 shows the pre-and postoperative comparison of the mean keratometric change for each group. Overcorrection was seen in the no CXL group, as expected due to the added ϩ0.50 D in the nomogram adjustment for this group, which seemed to decrease over the 2-year follow-up period. In eyes that received adjunct intrastromal CXL, no overcorrection was noted and greater stability was achieved.
RESULTS

Preoperatively
DISCUSSION
In previous studies, the potential advantage of using a topography-guided ablation profi le in the correction of hyperopic refractive errors has been demonstrated with greater importance than myopic errors because of the presence of angle kappa in hyperopes. 11 When treating with wavefront-optimized or wavefront-guided ablation, the treatment pattern is centered on the entrance pupil, whereas with topographic-guided ablation, it is centered on the corneal apex. Although much debate surrounds the best location for centration, evidence suggests that the corneal apex may be more closely aligned to the visual axis, especially when compensating for angle kappa in hyperopes. 15 In this study, we sought to evaluate the stability of these results after using intrastromal CXL. This, in theory, would act as a biomechanical modulator to the intrinsic corneal fl attening response of hyperopic LASIK seen during long-term follow-up. The keratometric regression noted over the 2 years of follow-up in the eyes randomized to not receive adjunctive intrastromal CXL confi rms, in our opinion, the abovementioned intrinsic biomechanical mechanism of regression in hyperopic LASIK. We believe this to be an "expansion" or "stretching" of the severed midperipheral corneal fi bers that have been ablated, resulting in progressive fl attening of the steepened central cornea. Although the possibility of midperipheral thickening and central thinning of the epithelium might also play a role in the regression, the fact that it was statistically minimized in the eyes undergoing intrastromal CXL points more clearly to the biomechanical mechanism.
The implication of biomechanical modulation of postoperative hyperopic LASIK regression, so as to prevent progressive refractive instability over time, sets a new level of dynamic control on the outcomes of Topography-guided Hyperopic LASIK and CXL/Kanellopoulos & Kahn laser vision correction surgery, which previously was restricted to a static change in refractive error. Just as the dynamic change of refraction seen with progressive keratoconus requires CXL to prevent the instability and irregularity of ectasia, in a similar way, the dynamic refractive and topographic regression of hyperopic LASIK now seems to require CXL to maintain stability over time. This also may be true of myopic regression seen in high myopic treatments with thin corneas, and is the reason why some have advocated LASIK Xtra (LASIK ϩ intrastromal CXL) for higher risk eyes. 14, 16 Our preliminary data suggest that the combination of high irradiance, short exposure intrastromal CXL may offer a signifi cant synergy in maintaining the long-term effi cacy and stability of topography-guided hyperopic LASIK (Fig 4) . However, we are unable to know or predict with certainty what will occur past 2 years based on these data. This synergy suggests that the regression of effect in hyperopic LASIK may be more related to corneal biomechanical changes than just a loss of residual accommodation, lens changes, or epithelial thickening. The use of CXL in association with LASIK may become another signifi cant application of corneal CXL and further expand the science of modulating biomechanical change in refractive surgery. 17 Finally, topography-guided LASIK with the EX500 excimer laser and FS200 femtosecond laser, with and without adjunctive intrastromal CXL, appears to be safe and effective in the correction of hyperopia and hyperopic astigmatism. 
